Treatment outcome and prognostic factors of adult glioblastoma multiforme

Abstract EN

Introduction : This study aimed to report the characteristics, prognostic factors and treatment outcome of 223 patients with glioblastoma multiforme (GBM).

Subjects and method : This retrospective study was carried out by reviewing the medical records of 223 adult patients diagnosed at a tertiary academic hospital between 1990 and 2008.

Patients’ follow up ranged from 1 to 69 months (median 11 months).

Surgery was attempted in all patients in whom complete resection in 15 patients (7 %), subtotal resection in 77 patients (34 %), partial resection in 73 patients (33 %) and biopsy alone in 58 patients (26 %) were done.

In addition, we performed a literature review of PubMed to find out and analyze major related series.

In all, we collected and analyzed the data of 33 major series including more than 11,000 patients with GBM.

Results: There were 141 men and 82 women.

The median progression free- and overall survival were 6 (95 % CI = 5.711–8.289) and 11 (95 % CI = 9.304–12.696) months respectively.

In univariate analysis for overall survival, age (P = 0.003), tumor size (P < 0.013), performance status (P < 0.001), the extent of surgical resection (P = 0.009), dose of radiation (P < 0.001), and adjuvant chemotherapy (P < 0.001) were prognostic factors.

However, in multivariate analysis, only radiation dose, extent of surgical resection, and adjuvant chemotherapy were independent prognostic factors for overall survival.

Conclusion : The prognosis of adult patients with GBM remains poor ; however, complete surgical resection and adjuvant treatments improve progression-free and overall survival.